Request Your Free Guide Now:

"Navigating patient access challenges when bringing your CGT product to market"

Cell and gene therapies (CGTs) are transformative modalities in personalized medicine. These groundbreaking advancements address unmet needs for life-threatening or debilitating conditions that have limited or no curative options. But manufacturers often find it challenging to commercialize CGTs successfully, with one major set of challenges involving patient access.

Factors affecting access include patients’ lack of awareness or hesitancy to pursue specific therapies. A complex coordination process and financial impact, both on patients and providers, can also negatively impact patient access. For your commercialization strategy to succeed, these challenges can be addressed through strategies such as:

• Increasing awareness of the patient support services you’re providing to ensure these services are utilized
• Coordinating the various services and stakeholders involved from enrollment through drug administration so patients continue to progress through their treatment journey
• Addressing patient proximity hurdles so patients can get to their treatment sites
• Working with various sites of care using alternative and flexible models

Discover recommendations intended to help you navigate patient access challenges so you can deliver on your CGT’s potential to improve patient lives.

Offered Free by: Cencora
See All Resources from: Cencora